Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;94(44):e1920.
doi: 10.1097/MD.0000000000001920.

Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes: A Meta-Analysis

Na Fang  1 , Wei Han, Dandan Gong, Zou Chen, Yu Fan
Affiliations
Review

Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes: A Meta-Analysis

Na Fang et al. Medicine (Baltimore). 2015 Nov.

Abstract

Impact of atorvastatin on carotid intima-media thickness (CIMT) in patients with type 2 diabetes is still debating.The aim of our study is to investigate atorvastatin as adjuvant treatment on CIMT in Chinese patients with type 2 diabetes by conducting a meta-analysis based on the randomized controlled trials (RCTs).A systematic search of electronic database of the Pubmed, EMBASE, Cochrane Library, VIP database, China National Knowledge Infrastructure, and Wangfang up to January 2015 was conducted. Randomized controlled trials (RCTs) comparing atorvastatin adjuvant treatment to the hypoglycemic therapies or high-dose atorvastatin versus low-dose atorvastatin therapies for patients with type 2 diabetes were selected.A total of 14 RCTs involving 1345 patients were included. Adjuvant treatment with atorvastatin was associated with a significant reduction in CIMT (weighted mean difference [WMD] = -0.17 mm; 95% confidence interval [CI] -0.22 to -0.12). Compared with the low-dose atorvastatin, high-dose atorvastatin treatment was associated with a significant reduction in CIMT (WMD = -0.17 mm; 95% CI: -0.32 to -0.02). Adjuvant treatment with atorvastatin reduced serum total cholesterol, triglyceride, low-density lipoproteins, and high sensitivity C-reactive protein levels. However, atorvastatin had no significant impact on blood glucose levels.This meta-analysis demonstrated that treatment with atorvastatin significantly reduced CIMT in Chinese patients with type 2 diabetes. Moreover, high-dose atorvastatin appeared to have additional benefits in reducing CIMT than the low-dose atorvastatin.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Flow diagram of study selection process.
FIGURE 2
FIGURE 2
Quality assessment of the included studies. Risk of bias graph (A); risk of bias summary (B).
FIGURE 3
FIGURE 3
Forest plots showing weighted mean differences with 95% confidence intervals for reduction in carotid intima–media thickness in a random effects model.
FIGURE 4
FIGURE 4
Funnel plots based on the changes of carotid intima–media thickness.
FIGURE 5
FIGURE 5
Forest plots showing standardized mean difference with 95% confidence intervals for improvement in serum high sensitivity C-reactive protein levels comparing atorvastatin to the control in a random effects model.
FIGURE 6
FIGURE 6
Subgroup analyses of carotid intima-media thickness changes based on the presence of carotid atherosclerosis or dyslipidemia.
See this image and copyright information in PMC

References

    1. Whiting DR, Guariguata L, Weil C, et al. Idf diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94:311–321. - PubMed
    1. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in china. N Engl J Med 2010; 362:1090–1101. - PubMed
    1. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA 2004; 292:2495–2499. - PubMed
    1. Jung CH, Baek AR, Kim KJ, et al. Association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes. Endocrinol Metab (Seoul) 2013; 28:309–319. - PMC - PubMed
    1. Sibal L, Agarwal SC, Home PD. Carotid intima–media thickness as a surrogate marker of cardiovascular disease in diabetes. Diabetes Metab Syndr Obes 2011; 4:23–34. - PMC - PubMed

MeSH terms

Substances